List of bibliographic references
Number of relevant bibliographic references: 16.
Ident. | Authors (with country if any) | Title |
---|
000018 (2014) |
Shumpei Yokota [Japon] ; Tomoyuki Imagawa ; Masaaki Mori ; Takako Miyamae ; Syuji Takei ; Naomi Iwata ; Hiroaki Umebayashi ; Takuji Murata ; Mari Miyoshi ; Minako Tomiita ; Norihiro Nishimoto ; Tadamitsu Kishimoto | Longterm Safety and Effectiveness of the Anti-interleukin 6 Receptor Monoclonal Antibody Tocilizumab in Patients with Systemic Juvenile Idiopathic Arthritis in Japan |
000019 (2014) |
Manabu Araki [Japon] ; Takako Matsuoka [Japon] ; Katsuichi Miyamoto [Japon] ; Susumu Kusunoki [Japon] ; Tomoko Okamoto [Japon] ; Miho Murata [Japon] ; Sachiko Miyake [Japon] ; Toshimasa Aranami [Japon] ; Takashi Yamamura [Japon] | Efficacy of the anti-IL-6 receptor antibody tocilizumab in neuromyelitis optica: A pilot study |
000045 (2013) |
Keiko Shimamoto [Japon] ; Tomoki Ito [Japon] ; Yoshio Ozaki [Japon] ; Hideki Amuro [Japon] ; Akihiro Tanaka [Japon] ; Tohru Nishizawa [Japon] ; YONSU SON [Japon] ; Muneo Inaba [Japon] ; Shosaku Nomura [Japon] | Serum Interleukin 6 Before and After Therapy with Tocilizumab Is a Principal Biomarker in Patients with Rheumatoid Arthritis |
000066 (2012) |
Atsushi Ogata [Japon] ; Noriko Umegaki [Japon] ; Ichiro Katayama [Japon] ; Atsushi Kumanogoh [Japon] ; Toshio Tanaka [Japon] | Rhumatisme psoriasique chez deux patients en échec de traitement par le tocilizumab |
000139 (2011) |
Masashi Narazaki [Japon] ; Keisuke Hagihara [Japon] ; Yoshihito Shima [Japon] ; Atsushi Ogata [Japon] ; Tadamitsu Kishimoto [Japon] ; Toshio Tanaka [Japon] | Therapeutic effect of tocilizumab on two patients with polymyositis |
000161 (2011) |
Atsushi Ogata [Japon] ; Atsuyoshi Morishima [Japon] ; Toru Hirano [Japon] ; Yoshihiro Hishitani [Japon] ; Keisuke Hagihara [Japon] ; Yoshihito Shima [Japon] ; Masashi Narazaki [Japon] ; Toshio Tanaka [Japon] | Improvement of HbA1c during treatment with humanised anti-interleukin 6 receptor antibody, tocilizumab |
000192 (2010) |
Toshio Tanaka [Japon] ; Keisuke Hagihara [Japon] ; Yoshihito Shima [Japon] ; Masashi Narazaki [Japon] ; Atsushi Ogata [Japon] ; Ichiro Kawase [Japon] ; Tadamitsu Kishimoto [Japon] | Treatment of a patient with remitting seronegative, symmetrical synovitis with pitting oedema with a humanized anti-interleukin-6 receptor antibody, tocilizumab |
000195 (2010) |
Yoshihito Shima [Japon] ; Yusuke Kuwahara [Japon] ; Hiroyuki Murota [Japon] ; Shun Kitaba [Japon] ; Mari Kawai [Japon] ; Toru Hirano [Japon] ; Junsuke Arimitsu [Japon] ; Masashi Narazaki [Japon] ; Keisuke Hagihara [Japon] ; Atsushi Ogata [Japon] ; Ichiro Katayama [Japon] ; Ichiro Kawase [Japon] ; Tadamitsu Kishimoto [Japon] ; Toshio Tanaka [Japon] | The skin of patients with systemic sclerosis softened during the treatment with anti-IL-6 receptor antibody tocilizumab |
000207 (2010) |
Soken-Nakazawa J. Song [Japon] ; Naohisa Tomosugi [Japon] ; Hiroshi Kawabata [Japon] ; Takayuki Ishikawa [Japon] ; Teppei Nishikawa [Japon] ; Kazuyuki Yoshizaki [Japon] | Down-regulation of hepcidin resulting from long-term treatment with an anti-IL-6 receptor antibody (tocilizumab) improves anemia of inflammation in multicentric Castleman disease |
000226 (2009) |
M. Kawai [Japon] ; K. Hagihara [Japon] ; T. Hirano [Japon] ; Y. Shima [Japon] ; Y. Kuwahara [Japon] ; J. Arimitsu [Japon] ; M. Narazaki [Japon] ; A. Ogata [Japon] ; I. Kawase [Japon] ; T. Kishimoto [Japon] ; T. Tanaka [Japon] | Sustained response to tocilizumab, anti-interleukin-6 receptor antibody, in two patients with refractory relapsing polychondritis |
000231 (2009) |
M. Hirao [Japon] ; J. Hashimoto [Japon] ; H. Tsuboi [Japon] ; A. Nampei [Japon] ; H. Nakahara [Japon] ; N. Yoshio [Japon] ; T. Mima [Japon] ; H. Yoshikawa [Japon] ; N. Nishimoto [Japon] | Laboratory and febrile features after joint surgery in patients with rheumatoid arthritis treated with tocilizumab |
000237 (2008) |
Yasuo Adachi [Japon] ; Naoko Yoshio-Hoshino [Japon] ; Norihiro Nishimoto [Japon] | The Blockade of IL-6 Signaling in Rational Drug Design |
000239 (2008) |
Norihiro Nishimoto [Japon] ; Kimio Terao [Japon] ; Toru Mima [Japon] ; Hideko Nakahara [Japon] ; Nobuhiro Takagi [Japon] ; Takahiro Kakehi [Japon] | Mechanisms and pathologic significances in increase in serum interleukin-6 (IL-6) and soluble IL-6 receptor after administration of an anti-IL-6 receptor antibody, tocilizumab, in patients with rheumatoid arthritis and Castleman disease |
000244 (2008) |
Yasuo Adachi [Japon] ; Naoko Yoshio-Hoshino [Japon] ; Norihiro Nishimoto [Japon] | Gene therapy for Multiple Myeloma |
000245 (2008) |
Tim Bongartz [États-Unis] ; Shumpei Yokota [Japon] ; Tomoyuki Imagawa [Japon] ; Masaaki Mori [Japon] ; Takako Miyamae [Japon] ; Yukoh Aihara [Japon] ; Shuji Takei [Japon] ; Naomi Iwata [Japon] ; Hiroaki Umebayashi [Japon] ; Takuji Murata [Japon] ; Mari Miyoshi [Japon] ; Minako Tomiita [Japon] ; Norihiro Nishimoto [Japon] ; Tadamitsu Kishimoto [Japon] | Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis : a randomised, double-blind, placebo-controlled, withdrawal phase III trial. Commentary |
000254 (2007) |
Naoko Yoshio-Hoshino [Japon] ; Yasuo Adachi [Japon] ; Chieko Aoki [Japon] ; Alexander Pereboev [États-Unis] ; David T. Curiel [États-Unis] ; Norihiro Nishimoto [Japon] | Establishment of a new lnterleukin-6 (IL-6) receptor inhibitor applicable to the gene therapy for IL-6-dependent tumor |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/PascalFrancis/Checkpoint
HfdIndexSelect -h $EXPLOR_AREA/Data/PascalFrancis/Checkpoint/AffRegInc.i -k "Osaka"
HfdIndexSelect -h $EXPLOR_AREA/Data/PascalFrancis/Checkpoint/AffRegInc.i \
-Sk "Osaka" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PascalFrancis/Checkpoint/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= TocilizumabV1
|flux= PascalFrancis
|étape= Checkpoint
|type= indexItem
|index= AffRegInc.i
|clé= Osaka
}}
| This area was generated with Dilib version V0.6.34. Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021 | |